Mergers & Acquisitions
Medtronic offers EU concessions in $43 billion Covidien deal
Medtronic inks $16B loan package for Covidien buyout
Salix inventory snafu sinks deal with Allergan
CareFusion’s Q1 sales, earnings rise
CareFusion (NYSE:CFN) ended its last fiscal quarter as a public company on a strong note, posting earnings growth of 2.8% on a top-line gain of 11.1%.
Wright Medical slashes losses, Q3 sales surge
The silver lining for healthcare in U.S. inversion rules
(Reuters) – Investors and bankers have been lamenting the potential death of large cross-border healthcare mergers since the U.S. Treasury Dept. announced in late September that it would curtail the tax breaks from international deals designed to give U.S. companies a legal home in a low-tax country.
Hologic beats with Q4 earnings, ditches MRI coils biz
Allergan in talks with 3rd-party acquirer
Siemens looks to consolidation, not growth, in 2015
SV Life Sciences buys majority stake in Ximedica
Ximedica said today that SV Life Sciences picked up a majority interest in the Providence, R.I.-based medical device development company from co-founders Stephen Lane and Aidan Petrie for an undisclosed amount.